Faq

Point-of-Care Testing (POCT) is critical because fast and accurate blood diagnostics enable rapid triage and treatment decisions. This is vital in high-risk cardiovascular cases where reducing dependency on delayed imaging can save lives.

The provided documents do not list specific medical risk factors. However, the testing platform is designed to adhere to the highest quality standards and uses blood-compatible biomarkers for clinical diagnostics.

The documents mention a global vision to be recognized as a leader in biomarker delivery. While it aims to redefine cardiac care worldwide, the files do not explicitly confirm current availability in every country.

Yes, the ASTRID platform is based on decades of clinical observation regarding the „diagnostic gap“ in cardiology. It is designed as a POCT IVDR (In Vitro Diagnostic Regulation) solution to ensure scientific excellence and accurate results.

While the documents do not detail a specific training manual, they emphasize that the platform is a point-of-care solution designed for healthcare providers to access rapid and accurate clinical diagnostics.

The ASTRID platform bridges physiology, biochemistry, and real-time analytics. It quantifies how the heart reacts to life stressors (infection, exercise, aging) by measuring functional cardiac resilience and kinetics of recovery rather than just cell necrosis.

The test is fast and reliable, providing accurate diagnostic results within 20 minutes.

The test is intended for multiple groups:

• Emergency patients needing rapid triage for myocardial infarction or arrhythmias.

• Athletes for cardiac safety profiling and post-infection clearance.

• Adults over 35 as part of annual screenings to detect sub-clinical cardiac shifts.

• Chronic patients for long-term monitoring of disease progression.